Strata Skin Sciences, Inc.
SSKN
$2.72
-$0.17-5.88%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -101.52% | 96.86% | -18.80% | -2,271.25% | -5.83% |
| Total Depreciation and Amortization | -14.17% | -10.87% | -10.52% | -6.67% | 11.61% |
| Total Amortization of Deferred Charges | 34.48% | -7.14% | -24.39% | -31.71% | -27.50% |
| Total Other Non-Cash Items | -108.31% | -90.74% | 52.17% | 716.88% | -44.57% |
| Change in Net Operating Assets | 117.14% | -160.08% | 242.45% | 189.97% | -70.78% |
| Cash from Operations | 85.05% | -37.59% | 1.59% | 741.34% | -191.07% |
| Capital Expenditure | -131.96% | 79.74% | 59.54% | -9.06% | 136.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -131.96% | 79.74% | 59.54% | -9.06% | 136.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | 100.00% | -- |
| Cash from Financing | 1,968.27% | -100.00% | -- | 100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.81% | -96.04% | 40.71% | 82.82% | -58.07% |
